Legal & General Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81M | Buy |
41,523
+1,486
| +4% | +$64.8K | ﹤0.01% | 2005 |
|
|
2025
Q1 | $1.1M | Sell |
40,037
-10
| -0% | -$274 | ﹤0.01% | 2158 |
|
|
2024
Q4 | $1.61M | Buy |
40,047
+2,818
| +8% | +$113K | ﹤0.01% | 2071 |
|
|
2024
Q3 | $1.76M | Sell |
37,229
-7,259
| -16% | -$344K | ﹤0.01% | 2034 |
|
|
2024
Q2 | $1.33M | Buy |
44,488
+2,003
| +5% | +$59.8K | ﹤0.01% | 2101 |
|
|
2024
Q1 | $1.71M | Buy |
42,485
+4,095
| +11% | +$165K | ﹤0.01% | 1999 |
|
|
2023
Q4 | $977K | Buy |
38,390
+7,382
| +24% | +$188K | ﹤0.01% | 2221 |
|
|
2023
Q3 | $431K | Sell |
31,008
-254
| -0.8% | -$3.53K | ﹤0.01% | 2492 |
|
|
2023
Q2 | $719K | Sell |
31,262
-3,753
| -11% | -$86.3K | ﹤0.01% | 2336 |
|
|
2023
Q1 | $1.04M | Buy |
35,015
+1,861
| +6% | +$55.1K | ﹤0.01% | 2139 |
|
|
2022
Q4 | $828K | Buy |
33,154
+424
| +1% | +$10.6K | ﹤0.01% | 2201 |
|
|
2022
Q3 | $713K | Buy |
32,730
+4,027
| +14% | +$87.7K | ﹤0.01% | 2250 |
|
|
2022
Q2 | $565K | Buy |
28,703
+258
| +0.9% | +$5.08K | ﹤0.01% | 2311 |
|
|
2022
Q1 | $1.2M | Buy |
28,445
+14,745
| +108% | +$624K | ﹤0.01% | 2178 |
|
|
2021
Q4 | $870K | Buy |
13,700
+305
| +2% | +$19.4K | ﹤0.01% | 2266 |
|
|
2021
Q3 | $787K | Buy |
13,395
+6,717
| +101% | +$395K | ﹤0.01% | 2303 |
|
|
2021
Q2 | $324K | Buy |
6,678
+4,956
| +288% | +$240K | ﹤0.01% | 2422 |
|
|
2021
Q1 | $67K | Sell |
1,722
-24
| -1% | -$934 | ﹤0.01% | 2737 |
|
|
2020
Q4 | $109K | Buy |
+1,746
| New | +$109K | ﹤0.01% | 2564 |
|